HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Henkel’s $2.9 Bil. Dial Acquisition To Bolster U.S. Presence

This article was originally published in The Rose Sheet

Executive Summary

Henkel's acquisition of Dial will strengthen the German firm's North American business by bolstering its personal care portfolio with the addition of the Dial, Coast and Tone soap brands, the company said, announcing the planned acquisition Dec. 15

You may also be interested in...



Dial takeover

Shareholders of record as of the close of business Feb. 24 will vote on Henkel's proposed acquisition of Dial during March 24 special meeting at firm's Scottsdale, Ariz. headquarters, Dial reports. Henkel announced plans to acquire the personal care company for $2.9 bil. in cash in December; under the proposed agreement, Dial shareholders would receive $28.75 per share. The acquisition, expected to close in April, also is subject to regulatory approval (1"The Rose Sheet" Dec. 22, 2003, p. 3)...

Dial takeover

Shareholders of record as of the close of business Feb. 24 will vote on Henkel's proposed acquisition of Dial during March 24 special meeting at firm's Scottsdale, Ariz. headquarters, Dial reports. Henkel announced plans to acquire the personal care company for $2.9 bil. in cash in December; under the proposed agreement, Dial shareholders would receive $28.75 per share. The acquisition, expected to close in April, also is subject to regulatory approval (1"The Rose Sheet" Dec. 22, 2003, p. 3)...

Sales & Earnings In Brief

P&G Q2: Beauty care net sales jumped 50% in the second quarter to $4.5 bil., boosted by Pantene, Head & Shoulders, Herbal Essences and Olay, firm reports Jan. 28. Net earnings rose 34% to $681 mil. on top line growth, including Wella. P&G will continue to support core brands such as Pantene, and will seek to improve its colorants business, which includes Clairol Herbal Essences highlighting kits and Nice 'N Easy permanent hair color, by creating better shopping and at-home coloring experiences for customers, CEO A.G. Lafley states. In health care, Crest Whitestrips and Night Effects led 22% net sales growth to $1.9 bil. Net earnings rose 32% to $333 mil. following "strong volume and margin expansion due to lower manufacturing costs and product mix," P&G notes. Overall net sales were up 20% to $13.2 bil., and net earnings improved 22% to $1.8 bil. Separately, Procter & Gamble International Operations announced a worldwide agreement to license Wella retail hair care products Jan. 29. "This is the first major agreement in the collaboration efforts between P&G and Wella and capitalizes on P&G's unique strengths in the consumer retail business," the companies note. P&G acquired Wella last year for $5 bil...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel